HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fei Yan Selected Research

Thrombosis (Thrombus)

8/2022The hemodynamic effect of eccentricity in visceral branched aneurysms with multilayer stents.
1/2020Initial Series of Robotic Segmental Inferior Vena Cava Resection in Left Renal Cell Carcinoma With Caval Tumor Thrombus.
1/2019Hemodynamics and Oxygen Transport through Pararenal Aortic Aneurysm Treated with Multilayer Stent: A Numerical Study.
6/2013[Anticoagulant efficacy and safety of argatroban for patients undergoing elective percutaneous coronary intervention].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fei Yan Research Topics

Disease

135Neoplasms (Cancer)
05/2024 - 12/2003
30Infections
04/2024 - 12/2013
24Breast Neoplasms (Breast Cancer)
01/2022 - 02/2010
17Inflammation (Inflammations)
04/2024 - 07/2005
17Virus Diseases (Viral Diseases)
03/2024 - 01/2012
14Neoplasm Metastasis (Metastasis)
02/2023 - 06/2011
12Leukemia
04/2023 - 07/2014
10Lung Neoplasms (Lung Cancer)
01/2023 - 03/2009
8Atherosclerosis
05/2024 - 01/2013
8Glioma (Gliomas)
06/2022 - 01/2018
8Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 10/2017
8Carcinoma (Carcinomatosis)
10/2021 - 03/2007
8Renal Cell Carcinoma (Grawitz Tumor)
01/2021 - 01/2015
7Gout
12/2023 - 01/2021
7Type 2 Diabetes Mellitus (MODY)
11/2023 - 01/2014
7Prostatic Neoplasms (Prostate Cancer)
09/2022 - 02/2015
7Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 09/2009
6Respiratory Syncytial Virus Infections
03/2024 - 01/2012
6Alzheimer Disease (Alzheimer's Disease)
02/2024 - 09/2018
6Hyperuricemia
01/2024 - 01/2021
6Obesity
11/2023 - 05/2015
6Glioblastoma (Glioblastoma Multiforme)
11/2022 - 01/2017
5Hyperthermia
04/2024 - 12/2016
5Heart Failure
10/2023 - 10/2012
5Necrosis
10/2023 - 04/2014
5Hepatocellular Carcinoma (Hepatoma)
06/2023 - 05/2012
5Wounds and Injuries (Trauma)
01/2022 - 11/2019
5Insulin Resistance
12/2021 - 06/2013
5Carcinogenesis
01/2020 - 03/2007
4Hypoxia (Hypoxemia)
12/2024 - 12/2006
4Pain (Aches)
01/2023 - 10/2017
4Thrombosis (Thrombus)
08/2022 - 06/2013
4Hemorrhage
02/2022 - 12/2012
4Fibrosis (Cirrhosis)
11/2019 - 01/2015
4Adenocarcinoma
02/2016 - 10/2008
3Myocardial Infarction
10/2023 - 01/2017
3Spinal Cord Injuries (Spinal Cord Injury)
10/2023 - 05/2020
3Ischemia
10/2023 - 06/2017
3Rheumatoid Arthritis
03/2023 - 10/2017
3Arthritis (Polyarthritis)
01/2023 - 10/2017

Drug/Important Bio-Agent (IBA)

34Proteins (Proteins, Gene)FDA Link
03/2024 - 12/2009
14Liposomes (Liposome)IBA
06/2021 - 01/2008
12Glucose (Dextrose)FDA LinkGeneric
12/2024 - 01/2014
11Peptides (Polypeptides)IBA
11/2023 - 06/2010
9Reactive Oxygen Species (Oxygen Radicals)IBA
04/2024 - 01/2016
9Antiviral Agents (Antivirals)IBA
03/2023 - 12/2013
8DNA (Deoxyribonucleic Acid)IBA
04/2024 - 01/2008
8LipidsIBA
06/2022 - 04/2014
8Doxorubicin (Adriamycin)FDA LinkGeneric
01/2019 - 06/2011
7Uric Acid (Urate)IBA
01/2024 - 01/2021
7Biomarkers (Surrogate Marker)IBA
01/2022 - 09/2014
7Paclitaxel (Taxol)FDA LinkGeneric
01/2022 - 05/2011
7MicroRNAs (MicroRNA)IBA
10/2019 - 01/2012
6RNA (Ribonucleic Acid)IBA
04/2024 - 01/2022
6Therapeutic UsesIBA
10/2023 - 01/2013
6Long Noncoding RNAIBA
10/2023 - 02/2016
6Messenger RNA (mRNA)IBA
01/2023 - 12/2006
6Coloring Agents (Dyes)IBA
08/2022 - 02/2015
62- (2- (2- chloro- 3- ((1,3- dihydro- 3,3- dimethyl- 1- propyl- 2H- indol- 2- ylidene)ethylidene)- 1- cyclohexen- 1- yl)ethenyl)- 3,3- dimethyl- 1- propylindoliumIBA
12/2020 - 02/2015
5InterferonsIBA
04/2024 - 06/2013
5Membrane Proteins (Integral Membrane Proteins)IBA
12/2023 - 05/2018
5Oxygen (Dioxygen)IBA
10/2023 - 01/2018
5Insulin (Novolin)FDA Link
01/2023 - 09/2014
5AntibodiesIBA
11/2022 - 01/2008
5GoldIBA
09/2022 - 01/2018
4ChitosanIBA
05/2024 - 09/2018
4Metal-Organic FrameworksIBA
04/2024 - 04/2020
4Blood Glucose (Blood Sugar)IBA
01/2024 - 01/2020
4Anti-Bacterial Agents (Antibiotics)IBA
01/2023 - 11/2022
4N-methyladenosineIBA
09/2022 - 11/2021
4IntegrinsIBA
09/2022 - 10/2015
4CytokinesIBA
01/2022 - 10/2007
46-methyladenineIBA
01/2022 - 11/2018
4Small Interfering RNA (siRNA)IBA
01/2022 - 01/2013
4Triglycerides (Triacylglycerol)IBA
12/2021 - 01/2014
4Photosensitizing Agents (Photosensitizers)IBA
01/2021 - 12/2003
4Fatty Acid-Binding ProteinsIBA
11/2018 - 06/2014
41-phenyl-3,3-dimethyltriazene (PDT)IBA
09/2018 - 12/2003
4SurvivinIBA
08/2018 - 12/2010
3oxidized low density lipoproteinIBA
05/2024 - 01/2020
3CholesterolIBA
05/2024 - 04/2014
3Transcription Factors (Transcription Factor)IBA
03/2024 - 01/2014
3icariinIBA
02/2024 - 01/2022
3CateninsIBA
02/2024 - 03/2015
3Peptide Initiation Factors (Initiation Factor)IBA
02/2024 - 02/2016
3FebuxostatFDA Link
12/2023 - 12/2022
3BenzbromaroneIBA
12/2023 - 01/2021
3Connexin 43 (Connexin43)IBA
10/2023 - 01/2022
3C-Reactive ProteinIBA
06/2023 - 09/2014

Therapy/Procedure

72Therapeutics
04/2024 - 03/2009
26Drug Therapy (Chemotherapy)
01/2023 - 12/2009
24Microbubbles
05/2024 - 05/2011
11Immunotherapy
04/2024 - 01/2018
9Photothermal Therapy
02/2024 - 01/2016
8Precision Medicine
11/2022 - 02/2016
7Lasers (Laser)
02/2024 - 01/2016
7Photochemotherapy (Photodynamic Therapy)
07/2021 - 12/2003
4Transplantation
10/2023 - 12/2016
4Stents
07/2023 - 12/2016
3Aftercare (After-Treatment)
01/2023 - 06/2019